Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 11, 2016, Pages 893-907

  Revilla, Ana ^a   González, Clara ^a   Iriondo, Amaia ^a   Fernández, Bárbara ^a   Prieto, Cristina ^a   Marín, Carlos ^a   Liste, Isabel ^a  

^a Unidad Funcional de Investigación en Enfermedades Crónicas   (Spain)

Author keywords

human induced pluripotent stem cells; iPS cells; pluripotency; regenerative medicine; reprogramming strategies; therapeutic potential

Indexed keywords

COPYRIGHTS; DIAGNOSIS; GENE TRANSFER; REGENERATIVE MEDICINE; STEM CELLS;

CELL SOURCES; CELL-BASED; HUMAN-INDUCED PLURIPOTENT STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; IPS CELLS; PLURIPOTENCY; REGENERATIVE MEDICINE; REPROGRAMMING STRATEGY; SOMATIC CELLS; THERAPEUTIC POTENTIALS;

CYTOLOGY;

CHEMICAL COMPOUND; EPISOMAL PLASMID VECTOR; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; PLASMID VECTOR; PROTEIN DERIVATIVE; RECOMBINANT PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

BIOENGINEERING; BIOTECHNOLOGY; BLOOD CELL; CELL MATURATION; CELL REPROGRAMMING TECHNIQUE; CELLS BY BODY ANATOMY; CLINICAL EFFECTIVENESS; DNA MODIFICATION; ECTODERM; EMBRYONIC STEM CELL; EPITHELIUM CELL; EXPRESSION VECTOR; FIBROBLAST; GENETIC ENGINEERING; HUMAN; HUMAN GENOME; HUMAN NASAL EPITHELIAL CELL; INDUCED PLURIPOTENT STEM CELL; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; MESODERM; MUTAGENESIS; PATIENT SAFETY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD CELL; UURINE DERIVED CELL; ANIMAL; GENETIC TRANSDUCTION; LENTIVIRINAE; PROCEDURES;

ANIMALS; CELLULAR REPROGRAMMING TECHNIQUES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; REGENERATIVE MEDICINE; TRANSDUCTION, GENETIC;

EID: 84924565721     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2021     Document Type: Review

References (120)

1. Aasen T, Izpisua Belmonte JC. 2010; Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5: 371–382.
2. Aasen T, Raya A, Barrero MJ et al. 2008; Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276–1284.
3. Abyzov A, Mariani J, Palejev D et al. 2013; Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492: 438–442.
4. Andrews PW, Cavagnaro J, Deans R et al. 2014; Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol 32: 724–726.
5. Anokye-danso F, Trivedi CM, Juhr D et al. 2012; Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8: 376–388.
6. Aoi T, Yae K, Nakagawa M et al. 2008; Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 32: 699–702.
7. Ban H, Nishishita N, Fusaki N et al. 2011; Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108: 2–7.
8. Bao X, Zhu X, Liao B et al. 2013; MicroRNAs in somatic cell reprogramming. Curr Opin Cell Biol 25: 208–214.
9. Bar-Nur O, Brumbaugh J, Verheul C et al. 2014; Small molecules facilitate rapid and synchronous iPSC generation. Nat Methods 11: 1170–1176. DOI: 10.1038/nmeth.3142.
10. Bayart E, Cohen-Haguenauer O. 2013; Technological overview of iPS induction from human adult somatic cells. Curr Gene Ther 13: 73–92.
11. Ben-David U, Benvenisty N. 2011; The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11: 268–277.
12. Bernal JA. 2013; RNA-Based Tools for Nuclear reprogramming and lineage-conversion: towards clinical applications. J Cardiovasc Transl Res 6: 956–968.
13. Brambrink T, Foreman R, Welstead GG et al. 2008; Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151–159.
14. Chen G, Gulbranson DR, Hou Z et al. 2011; Chemically defined conditions for human iPS cell derivation and culture. Nat Methods 8: 424–429.
15. Cho HJ, Lee CS, Kwon YW et al. 2010; Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116: 386–395.
16. Chou BK, Mali P, Huang X et al. 2011; Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21: 518–529.
17. Cyranoski D. 2014; Nature News. Nature 516: 162–164. DOI: 10.1038/nature.2014.15897.
18. Deng J, Shoemaker R, Xie B et al. 2009; Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27: 353–360.
19. Di Matteo M, Belay E, Chuah MK et al. 2012; Recent developments in transposon-mediated gene therapy. Expert Opin Biol Ther 12: 841–858.
20. Dowey SN, Huang X, Chou BK et al. 2012; Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc 7: 2013–2021.
21. Durruthy Durruthy J, Sebastiano V. 2014; Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs. Methods Mol Biol 1283: 31–42.
22. Eminli S, Utikal J, Arnold K et al. 2008; Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26: 2467–2474.
23. Eminli S, Foudi A, Stadtfeld M et al. 2009; Differentiation stage determines reprogramming potential of hematopoietic cells into iPS cells. Nat Genet 41: 968–976.
24. Esteban MA, Pei D. 2012; Vitamin C improves the quality of somatic cell reprogramming. Nat Genet 44: 366–367.
25. Esteban MA, Wang T, Qin B et al. 2010; Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6: 71–79.
26. Ezeh UI, Turek PJ, Reijo RA et al. 2005; Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255–2265.
27. Fu X, Xu Y. 2012; Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med 4(6): 1–10.
28. Fusaki N, Ban H, Nishiyama A et al. 2009; Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. J Jpn Acad B Phys 85: 348–362.
29. Garber K. 2013; Inducing translation. Nat Biotechnol 31: 483–486.
30. Giorgetti A, Montserrat N, Aasen T et al. 2009; Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5: 353–357.
31. Gonzalez F, Barragan-Monasterio M, Tiscornia G et al. 2009; Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A 106: 8918–8922.
32. Gonzalez F, Boue S, Izpisua Belmonte JC. 2011; Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat Rev Genet 12: 231–242.
33. Grabundzija I, Wang J, Sebe A et al. 2013; Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res 41: 1829–1847.
34. Guan D, Zhang W, Liu GH et al. 2013; Switching cell fate, ncRNAs coming to play. Cell Death Dis 4(1): e464.
35. Haase A, Olmer R, Schwanke K et al. 2009; Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5: 434–441.
36. Hou P, Li Y, Zhang X et al. 2013; Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341: 651–654.
37. Hu K, Yu J, Suknuntha K et al. 2011; Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117: e109–e119.
38. Huangfu K, Maehr R, Guo W et al. 2008; Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795–797.
39. Inoue H, Nagata N, Kurokawa H et al. 2014; iPS cells: a game changer for future medicine. EMBO J 33: 409–417.
40. Ji J, Ng SH, Sharma V et al. 2012; Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30: 435–440.
41. Jia F, Wilson KD, Sun N et al. 2010; A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7: 197–199.
42. Kaji K, Norrby K, Paca A et al. 2009; Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239): 771–775.
43. Kamao H, Mandai M, Okamoto S et al. 2014; Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep 2(2): 205–218.
44. Khan M, Narayanan K, Lu H et al. 2013; Delivery of reprogramming factors into fibroblast for generation of non-genetic induced pluripotent stem cells using a cationic bolamphiphile as a non-viral vector. Biomaterials 34: 5336–5343.
45. Kim D, Kim CH, Moon JI et al. 2009a; Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472–476.
46. Kim JB, Greber B, Arauzo-Bravo MJ et al. 2009b; Direct reprogramming of human neural stem cells by OCT4. Nature 461: 649–653.
47. Kim JB, Zaehres H, Wu G et al. 2008; Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646–650.
48. Kim K, Do A, Wen B et al. 2010; Epigenetic memory in induced pluripotent stem cells. Nature 467: 285–290.
49. Kim K, Zhao R, Doi A et al. 2013; Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nature 29: 1117–1119.
50. Li H, Collado M, Villasante A et al. 2009; The Ink4/Arf locus is a barrier for iPS reprogramming. Nature 460: 1136–1139.
51. Li Y, Zhang Q, Yin X et al. 2011; Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res 21: 196–204.
52. Lin SL, Chang DC, Lin CH et al. 2011; Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 39: 1054–1065.
53. Lister R, Pelizzola M, Kida YS et al. 2011; Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68–73.
54. Loh YH, Agarwal S, Park IH et al. 2009; Generation of induced pluripotent stem cells from human blood. Blood 113: 5476–5479.
55. Lowry WE, Richter L, Yachechko R et al. 2008; Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105: 2883–2888.
56. Macarthur CC, Fontes A, Ravinder N et al. 2012; Generation of human induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012: 564612.
57. + cells across blood drawn from multiple donors with non-integrating episomal vectors. PLoS One 6: e27956.
58. Maherali N, Sridharan R, Xie W et al. 2007; Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55–70.
59. Mali P, Chou BK, Yen J et al. 2010; Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28: 713–720.
60. Mandal PK, Rossi DJ. 2013; Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8: 568–582.
61. Masuda S, Wu J, Hishida T et al. 2013; Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach. J Mol Cell Biol 5: 354–355.
62. + cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther 20: 408–416.
63. Miyoshi N, Ishii H, Nagano H et al. 2011; Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8: 633–638.
64. Montserrat N, Garreta E, Gonzalez F et al. 2011; Simple generation of human induced pluripotent stem cells using poly-β-amino esters as the non-viral gene delivery system. J Biol Chem 286: 12417–12428.
65. Nakagawa M, Koyanagi M, Tanabe K et al. 2008; Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101–106.
66. Nakanishi M, Otsu M. 2012; Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr Gene Ther 12: 410–416.
67. Narsinh KH, Jia F, Robbins RC et al. 2011; Generation of adult human induced pluripotents stem cells using nonviral minicircle DNA vectors. Nat Protoc 6: 78–88.
68. Okita K, Ichisaka T, Yamanaka S. 2007; Generation of germline-competent induced pluripotent stem cells. Nature 448: 313–317.
69. Okita K, Matsumura Y, Sato Y et al. 2011; A more efficient method to generate integration-free human iPS cells. Nat Methods 8: 409–412.
70. Okita K, Nakagawa M, Hyenjong H et al. 2008; Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949–953.
71. Okita K, Yamakawa T, Matsumura Y et al. 2013; An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31: 458–466.
72. Ono M, Hamada Y, Horiuchi Y et al. 2012; Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector. PLoS One 7: e42855.
73. Pasi CE, Dereli-Oz A, Negrini S et al. 2011; Genomic instability in induced stem cells. Cell Death Diff 18(5): 745–753.
74. Piao Y, Hung SS, Lim SY et al. 2014; Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors. Stem Cells Transl Med 3: 787–791.
75. Plews JR, Li J, Jones M et al. 2010; Activation of pluripotency genes in human fibroblast cells by a novel mRNA-based approach. PLoS One 5: e14397.
76. Rhee YH, Ko JY, Chang MY et al. 2011; Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson's disease. J Clin Invest 121: 2326–2335.
77. Rowland BD, Peeper DS. 2006; KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6: 11–23.
78. Sanchez Alvarado A, Yamanaka S. 2014; Rethinking differentiation: stem cells, regeneration, and plasticity. Cell 157(1): 110–119.
79. Seki S, Yuasa S, Fukuda K. 2012; Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc 7: 718–728.
80. Seki T, Yuasa S, Oda M et al. 2010; Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7: 11–14.
81. Si-Tayeb K, Noto FK, Sepac A et al. 2010; Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol 10: 1–10.
82. Soldner FD, Hockemeyer D, Beard C et al. 2009; Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964–977.
83. Stadtfeld M, Nagaya M, Utikal J et al. 2008; Induced pluripotent stem cells generated without viral integration. Science 322: 945–949.
84. Staerk J, Dawlaty MM, Gao Q et al. 2010; Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7: 20–24.
85. Stephen SL, Sivanandam VG, Kochanek S. 2008; Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA. J Gene Med 10: 1176–1189.
86. Streckfuss-Bomeke K, Wolf F, Azizian A et al. 2013; Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J 34: 2618–2629.
87. Sun N, Panetta NJ, Gupta DM et al. 2009; Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 106: 15720–15725.
88. Takahashi K, Yamanaka S. 2006; Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
89. Takahashi K, Tanabe K, Ohnuki M et al. 2007; Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861–872.
90. Tanabe K, Takahashi K, Yamanaka S. 2014; Induction of pluripotency by defined factors. Proc Jpn Acad Ser B Phys Biol Sci 90: 83–96.
91. Thomson JA, Itskoviz-Eldor J, Shapiro SS et al. 1998; Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
92. Ukital J, Maherali N, Kulalert W et al. 2009; Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122: 3502–3510.
93. Wang Q, Xu X, Li J et al. 2011; Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res 21: 1424–1435.
94. Warren L, Manos PD, Ahfeldt T et al. 2010; Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618–630.
95. Wernig M, Lengner CJ, Hanna J et al. 2008; A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26: 916–924.
96. Wernig M, Meissner A, Foreman R et al. 2007; In vitro reprogramming of fibroblasts into a pluripotent ES cell-like state. Nature 448: 318–324.
97. West JA, Viswanathan SR, Yabuchi A et al. 2009; A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460(7257): 909–913.
98. Woltjen K, Michael IP, Mohseni P et al. 2009; PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766–770.
99. Wu YL, Pandian GN, Ding YP et al. 2013; Clinical grade iPS Cells: need for versatile small molecules and optimal cell sources. Chem Biol 20: 1311–1322.
100. Xu X, Wang Q, Long Y et al. 2013a; Stress-mediated p38 activation promotes somatic cell reprogramming. Cell Res 23: 131–141.
101. Xu Y, Wei X, Wang M et al. 2013b; Proliferation rate of somatic cells affects reprogramming efficiency. J Biol Chem 288: 9767–9778.
102. Xue Y, Cai X, Wang L et al. 2013; Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One 8: e70573.
103. Yamanaka S. 2007; Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39–49.
104. Yamanaka S. 2009; A fresh look at iPS cells. Cell 137: 13–17.
105. Yan X, Qin H, Qu C et al. 2010; iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 19: 469–4980.
106. Ye Z, Zhan H, Mali P et al. 2009; Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114: 5473–5480.
107. Ye L, Muench MO, Fusaki MN et al. 2013; Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med 2: 558–566.
108. Yoshioka N, Gros E, Li HR et al. 2013; Efficient generation of human iPS cells by synthetic self-replicative RNA. Cell Stem Cell 13: 1–21.
109. Yu J, Chau KF, Vodyanik MA et al. 2011; Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6: e17557.
110. Yu J, Hu K, Smuga-Otto K et al. 2009; Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797–801.
111. Yu J, Vodyanik MA, Smuga-Otto K et al. 2007; Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858): 1917–1920.
112. Yusa K, Rad R, Takeda J et al. 2009; Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6: 363–369.
113. Zhang X, de los Angeles A, Zhang J. 2010; The art of human induced pluripotent stem cells: the past, the present and the future. Open Stem Cell J 2: 2–7.
114. Zhao T, Zhang ZN, Rong Z et al. 2011; Immunogenicity of induced pluripotent stem cells. Nature 474: 212–215.
115. Zhao T, Xu Y. 2010; p53 and stem cells: new developments and new concerns. Trends Cell Biol 20(3): 170–175.
116. Zhou H, Wu S, Joo JY et al. 2009; Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381–384.
117. Zhou T, Benda C, Duzinger S et al. 2011; Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 22: 1221–1228.
118. Zhou T, Benda C, Dunzinger S et al. 2012; Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7: 2080–2089.
119. Zhou W, Freed CR. 2009; Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27: 2667–2674.
120. Zuo B, Yang J, Wang F et al. 2012; Influences of lamin A levels on induction of pluripotent stem cells. Biol Open 1: 1118–1127.